| Pharmacology of drugs that alter multidrug resistance in cancer F JM Pharmacol Rev 42, 155-199, 1990 | 1372 | 1990 |
| Homologous recombination deficiency (HRD) score predicts response to platinum-containing neoadjuvant chemotherapy in patients with triple-negative breast cancer ML Telli, KM Timms, J Reid, B Hennessy, GB Mills, KC Jensen, Z Szallasi, ... Clinical cancer research 22 (15), 3764-3773, 2016 | 893 | 2016 |
| Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair BJ Hwang, JM Ford, PC Hanawalt, G Chu Proceedings of the National Academy of Sciences 96 (2), 424-428, 1999 | 745 | 1999 |
| Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers RS van der Post, IP Vogelaar, F Carneiro, P Guilford, D Huntsman, ... Journal of medical genetics 52 (6), 361-374, 2015 | 638 | 2015 |
| Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines AA Powell, AAH Talasaz, H Zhang, MA Coram, A Reddy, G Deng, ML Telli, ... PloS one 7 (5), e33788, 2012 | 638 | 2012 |
| American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility ME Robson, AR Bradbury, B Arun, SM Domchek, JM Ford, HL Hampel, ... Journal of Clinical Oncology 33 (31), 3660-3667, 2015 | 588 | 2015 |
| p53-mediated DNA repair responses to UV radiation: studies of mouse cells lacking p53, p21, and/orgadd45 Genes ML Smith, JM Ford, MC Hollander, RA Bortnick, SA Amundson, YR Seo, ... Molecular and cellular biology, 2000 | 565 | 2000 |
| Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer P Kaurah, A MacMillan, N Boyd, J Senz, A De Luca, N Chun, G Suriano, ... Jama 297 (21), 2360-2372, 2007 | 524 | 2007 |
| Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment AW Kurian, EE Hare, MA Mills, KE Kingham, L McPherson, ... Journal of clinical oncology 32 (19), 2001, 2014 | 522 | 2014 |
| Clinical interpretation and implications of whole-genome sequencing FE Dewey, ME Grove, C Pan, BA Goldstein, JA Bernstein, H Chaib, ... Jama 311 (10), 1035-1045, 2014 | 514 | 2014 |
| Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria AR Brooks-Wilson, P Kaurah, G Suriano, S Leach, J Senz, N Grehan, ... Journal of medical genetics 41 (7), 508-517, 2004 | 489 | 2004 |
| Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. JM Ford, PC Hanawalt Proceedings of the National Academy of Sciences 92 (19), 8876-8880, 1995 | 470 | 1995 |
| Expression of wild-type p53 is required for efficient global genomic nucleotide excision repair in UV-irradiated human fibroblasts JM Ford, PC Hanawalt Journal of Biological Chemistry 272 (44), 28073-28080, 1997 | 453 | 1997 |
| Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas DT Chang, D Schellenberg, J Shen, J Kim, KA Goodman, GA Fisher, ... Cancer 115 (3), 665-672, 2009 | 432 | 2009 |
| p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene S Adimoolam, JM Ford Proceedings of the National Academy of Sciences 99 (20), 12985-12990, 2002 | 430 | 2002 |
| Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer AC Koong, E Christofferson, QT Le, KA Goodman, A Ho, T Kuo, JM Ford, ... International Journal of Radiation Oncology* Biology* Physics 63 (2), 320-323, 2005 | 400 | 2005 |
| Strategies to identify the Lynch syndrome among patients with colorectal cancer: a cost-effectiveness analysis U Ladabaum, G Wang, J Terdiman, A Blanco, M Kuppermann, CR Boland, ... Annals of internal medicine 155 (2), 69-79, 2011 | 389 | 2011 |
| Xeroderma pigmentosum p48 gene enhances global genomic repair and suppresses UV-induced mutagenesis JY Tang, BJ Hwang, JM Ford, PC Hanawalt, G Chu Molecular cell 5 (4), 737-744, 2000 | 389 | 2000 |
| Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer D Schellenberg, KA Goodman, F Lee, S Chang, T Kuo, JM Ford, ... International Journal of Radiation Oncology* Biology* Physics 72 (3), 678-686, 2008 | 382 | 2008 |
| The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ... Cell 181 (2), 236-249, 2020 | 381 | 2020 |
